The expression of MEG3 in many primary human tumors is significantly lower than that in normal adjacent tissues, including neuroblastomas [22], lung cancers [23], liver cancers [24], gliomas [25], prostate cancers [26], and colon cancers [27]. This evidence concerns the gene MEG3 and neuroblastoma.